Company Overview and News

Eye On Stock, Malaysia Buiding Society

MALAYSIA Building Society Bhd (code: 1171) spiked on the first day of the past trading week, which saw it hit a resistance of RM1.24 before gravitating to a lower close of RM1.19.

MBSB Bank to focus on compliance, CTI ratio set to rise

Compliance culture: (from left) MBSB Bank chairman Tan Sri Abdul Halim Ali, Second Finance Minister Datuk Seri Johari Abdul Ghani and Ahmad Zaini at the launch of MBSB Bank merged brandname and logo.

Asian Finance Bank now officially MBSB Bank, looks to adopt fintech into business

2018-04-02 themalaymailonline
(From left) MBSB chairman Tan Sri Abdul Halim Ali, Datuk Seri Johari Abdul Ghani and MBSB president and CEO Datuk Seri Ahmad Zaini Othman at the launch of the Asian Finance Bank, Kuala Lumpur April 2, 2018. — Picture by Firdaus LatifKUALA LUMPUR, April 2 — After a successful acquisition by the Malaysia Building Society Berhad (MBSB), the Asian Finance Bank (AFB) has now officially been rebranded as MBSB Bank Berhad, positioning itself as an Islamic bank.

Malaysia Building Society completes acquisition of Asian Finance Bank

2018-02-07 themalaymailonline
UALA LUMPUR, Feb 7 — Malaysia Building Society Bhd (MBSB) has completed the acquisition of Asian Finance Bank Bhd (AFB).

MBSB completes purchase of AFB

KUALA LUMPUR: Malaysia Building Society Bhd (MBSB) said Asian Finance Bank (AFB) is now a wholly owned subsidiary after it acquired all shares in the bank for RM644.95mil.

Trading ideas: EcoFirst, Genetec, Ikhmas Jaya, MBSB, Pintaras, Salcon

KUALA LUMPUR: EcoFirst Consolidated Bhd , Genetec Technology Bhd , Pintaras Jaya Bhd , Malaysia Building Society Bhd (MBSB) and Salcon Bhd are among the stocks to watch on Friday, accoding to JF Apex Research.

MBSB’s shares rise as earnings beat forecast

KUALA LUMPUR: Malaysia Building Society Bhd (MBSB)’s shares rose 4% in early trade Friday, after its fourth quarter earnings came in ahead of estimates.

MBSB’s net profit up 172% on lower cost of funds

PETALING JAYA: Malaysia Building Society Bhd ’s (MBSB) net profit rose 171.98% to RM123.98mil in its fourth quarter ended Dec 31, 2017 (4Q17), driven by lower cost of funds and lower allowances for impairment losses on financing, loans and advances. Revenue was almost unchanged at RM818.27mil from RM819.4mil previously.

Trading ideas: TM, TNB, MBSB, Caely, UMW O&G

KUALA LUMPUR: Telekom Malaysia Bhd , Tenaga Nasional Bhd , Malaysia Building Society Bhd (MBSB) and Caely Holdings Bhd are among the stocks to watch on Wednesday, according to JF Apex Research.

MBSB to rollout up to RM700m financing for Rumawip projects

Affordable housing: Tengku Adnan viewing a model of the Rumawip project. Residensi Hektar has received encouraging response from potential buyers with a current take-up rate of 60 for the project. — Bernama

MBSB to provide RM700m funding for eight Rumawip projects

2018-01-16 themalaymailonline
Federal Territories Minister Datuk Seri Tengku Adnan Tengku Mansor (third left) inspecting a show unit of the Federal Territories Affordable Housing (Rumawip) apartment at the Hektar Residency sales office, Setapak, January 16, 2018. — Bernama picKUALA LUMPUR, Jan 16 — Malaysia Building Society Bhd (MBSB) is planning to rollout up to RM700 million in financing for the development of eight more Federal Territories Affordable Housing (Rumawip) projects.

PNB to work on issuance of Maybank Islamic shares

“We were hoping for the i-shares initiative to be approved in 2017 but unfortunately this has yet to materialise. “We will continue to engage with relevant stakeholders to hopefully make this a reality in 2018,” PNB group chairman Tan Sri Abdul Wahid Omar(pic) said.

PNB to increase exposure to private investments domestically and internationally

2017-12-31 themalaymailonline
PNB chairman Tan Sri Abdul Wahid Omar said PNB would increase its exposure to private investments both domestically and internationally. — Bernama file picKUALA LUMPUR, Dec 31 — Permodalan Nasional Bhd (PNB) would increase its exposure to private investments both domestically and internationally subject to the right opportunity, said its Chairman, Tan Sri Abdul Wahid Omar.

Year-end rally in the works?

PETALING JAYA: Some large caps on Bursa Malaysia are poised for active buying this week as major funds such as Permodalan Nasional Bhd (PNB) and the Employees Provident Fund (EPF) head closer to their book closures, dealers said.

Solar Management secures RM247mil financing for solar project

(from left) Malaysia Building Society Bhd (MBSB) senior VP Datuk Nor Azam M Taib, president and CEO Datuk Seri Ahmad Zaini Othman, Solar Management (Seremban) Sdn Bhd director Tee Cheng Hua and director Jane Tee at the signing ceremony.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...